[EN] COMPOUNDS FOR STABILIZING RYANODINE RECEPTORS FROM ABERRANT LEVELS OF CALCIUM RELEASE<br/>[FR] COMPOSÉS POUR STABILISER DES RÉCEPTEURS DE RYANODINE À PARTIR DE NIVEAUX ABERRANTS DE LIBÉRATION DE CALCIUM
申请人:UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE
公开号:WO2014144654A1
公开(公告)日:2014-09-18
Disclosed herein are methods and compositions comprising compounds capable of normalizing neuronal calcium dyshomeostasis. Also disclosed are methods comprising these compounds for treating neuronal or neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, fronto-temporal dementia, Pick's disease, chronic traumatic encepholopathy, traumatic brain injury, stroke, cerebellar ataxia, multiple sclerosis, Down syndrome, and aging-related CNS disorders.